High Court Seeks Lamictal Buyers' Views On Antitrust Appeal
The U.S. Supreme Court has asked purchasers of the anticonvulsant Lamictal to respond to GlaxoSmithKline's and Teva's argument that the justices should review a Third Circuit decision allowing the drug buyers...To view the full article, register now.
Already a subscriber? Click here to view full article